Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

Media Centre

As a company that is constantly developing and extending its range of healthcare products, it is important to keep both customers, distributors, medical professionals, patients and shareholders up to date with the latest MDI developments. Along with the latest product and industry news, information for professional healthcare workers such as upcoming conferences and tradeshows where MDI will be represented, will be posted here. As this page will be continually updated, please visit here regularly to see the latest news.

News

  • MVP Completes $25m Placement
    Dec 14 2020/ 0 Comment
    14 December 2020 ASX ANNOUNCEMENT Medical Developments completes a A$25 million placement to accelerate the commercialis
  • EU Transition and Trading Update
    Dec 3 2020/ 0 Comment
    3 December 2020 ASX ANNOUNCEMENT EU Transition and Trading Update Medical Developments International Limited (ASX: MVP)
  • MVP Board Re-organisation
    Dec 3 2020/ 0 Comment
    3 December 2020 ASX ANNOUNCEMENT MVP Board Re-organisation Medical Developments International Limited (ASX: MVP) today a
  • MVP and MundiPharma cease Australian licensing agreement
    Oct 30 2020/ 0 Comment
    30 October 2020 ASX ANNOUNCEMENT MVP and MundiPharma agree to cease distribution and licensing agreement in Australia MV
  • 2020 AGM Chairman and CEO Address to Shareholders
    Oct 28 2020/ 0 Comment
    28 October 2020 ASX ANNOUNCEMENT Chairman’s and CEO’s Address to Shareholders Medical Developments International Limited
  • Appointment of CEO and Non-Executive Director
    Oct 14 2020/ 0 Comment
    14 October 2020 ASX ANNOUNCEMENT Appointment of Chief Executive Officer – Brent MacGregor Medical Developments Internati
  • Head of Europe Appointed
    Aug 19 2020/ 0 Comment
    19 August 2020 ASX ANNOUNCEMENT Head of Europe Appointed Medical Developments International (ASX: MVP) is pleased to ann
  • MVP to take control of EU markets
    Aug 19 2020/ 0 Comment
    19 August 2020 ASX ANNOUNCEMENT Medical Developments to take control of EU markets Medical Developments International (A
  • Appointment of Non Executive Director – Christine Emmanuel
    May 26 2020/ 0 Comment
    26 May 2020 ASX ANNOUNCEMENT Appointment of Non-Executive Director – Christine Emmanuel Medical Developments Internation
  • Penthrox approved in Hungary
    May 25 2020/ 0 Comment
    25 May 2020 ASX Announcement Penthrox approved in Hungary Medical Developments International Limited (ASX: MVP) is delig
  • Penthrox approved in The Netherlands and Bosnia & Herzegovina
    May 5 2020/ 0 Comment
    5 May 2020 ASX Announcement Penthrox approved in The Netherlands and Bosnia & Herzegovina. Medical Developments Inte
  • Penthrox is approved in Thailand
    Apr 28 2020/ 0 Comment
    28 April 2020 ASX Announcement Penthrox is approved in Thailand Medical Developments International Limited (ASX: MVP), a
  • FY20 Half Year Report and Accounts
    Feb 19 2020/ 0 Comment
    19 February 2020 ASX ANNOUNCEMENT MVP has today released its FY20 Half Year Report and Accounts. Please refer to the fol
  • Penthrox Marketing Authorisation Application in Russia
    Dec 6 2019/ 0 Comment
    6 December 2019 ASX ANNOUNCEMENT Penthrox Marketing Authorisation Application in Russia Medical Developments Internation
  • Penthrox IND approved in China
    Nov 21 2019/ 0 Comment
    21 November 2019 ASX ANNOUNCEMENT Penthrox IND approved in China Medical Developments International Limited (ASX: MVP) i
  • MVP signs new Manufacturing Development Project with CSIRO
    Oct 29 2019/ 0 Comment
    29 October 2019 ASX ANNOUNCEMENT MVP signs new Manufacturing Development Project with CSIRO Medical Developments Interna
  • Penthrox approved in EUSEM guidelines
    Oct 25 2019/ 0 Comment
    24 October 2019 ASX Announcement Penthrox® entered in the European Society of Emergency Medicine (EUSEM) guidelines as n
  • Penthrox is launched in Italy
    Oct 23 2019/ 0 Comment
    23 October 2019 ASX Announcement Penthrox? is launched in Italy Medical Developments International Ltd (ASX: MVP) is del
  • Positive study results for Penthrox in Europe
    Oct 23 2019/ 0 Comment
    22 October 2019 ASX Announcement Positive study results for Penthrox? demonstrating superiority over Standard of Care fo
  • Preliminary Final Report and Full Year Accounts
    Aug 21 2019/ 0 Comment
    21 August 2019 ASX Announcement Preliminary Final Report and Full Year Accounts   For the full report please click
  • Penthrox USA Update
    Jul 19 2019/ 0 Comment
    19 July 2019 ASX Announcement Penthrox – USA Update Medical Developments International Limited (ASX: MVP) advises
  • Licensing deal for Penthrox in Australia
    Jun 3 2019/ 0 Comment
    3 June 2019 ASX ANNOUNCEMENT Licensing deal for Penthrox in Australia Medical Developments International Limited (ASX: M
  • MVP – Half Year Report and Accounts
    Feb 20 2019/ 0 Comment
    20 February 2019 HALF-YEAR REPORT Pursuant to listing rule 4.2A, please find following Medical Developments Internationa
  • Trading and Market Update
    Oct 30 2018/ 0 Comment
    30 October 2018 ASX Announcement Trading and market update Please refer to the following link for a trading and market u
  • Chairman’s and CEO’s Address to Shareholders
    Oct 30 2018/ 0 Comment
    Please refer to the following link for the Chairman’s and CEO’s Address to Shareholders, as provided at the
  • Penthrox is approved in Saudi Arabia
    Oct 11 2018/ 0 Comment
    11 October 2018 ASX Announcement Penthrox is approved in Saudi Arabia Medical Developments International Limited (ASX:MV
  • MVP signs exclusive Penthrox deal for China
    Oct 7 2018/ 0 Comment
    8 October 2018 ASX Announcement MVP signs exclusive Penthrox deal for China with Daiichi Sankyo Medical Developments Int
  • Share Purchase Plan
    Sep 19 2018/ 0 Comment
    19 September 2018 ASX Announcement Share Purchase Plan Medical Developments International (ASX: MVP) (Company) advises t
  • Penthrox: USA update
    Aug 29 2018/ 0 Comment
    29 August 2018 ASX Announcement Penthrox: USA update Medical Developments International Limited (ASX: MVP) advise that i
  • Preliminary Final Report and Full Year Accounts
    Aug 16 2018/ 0 Comment
    17 August 2018 ASX Announcement Preliminary Final Report and Full Year Accounts   For the full report please click
  • Capital Raising – Placement and Share Purchase Plan
    Aug 8 2018/ 0 Comment
    8 August 2018 ASX ANNOUNCEMENT Capital Raising – Placement and Share Purchase Plan 1. Placement Medical Developmen
  • FY18 Results Update
    Aug 6 2018/ 0 Comment
    For the full ASX Announcement “FY18 Results Update” please click on the following link:ASX Announcement
  • USA Update
    Jul 25 2018/ 0 Comment
    25 July 2018 ASX ANNOUNCEMENT USA Update Medical Developments International (ASX: MVP) today advised that it met with th
  • Penthrox approved in Italy, The Czech Republic and Spain
    Jul 16 2018/ 0 Comment
    16 July 2018 ASX Announcement Penthrox approved in Italy, The Czech Republic and Spain. Medical Developments Internation
  • Penthrox approved in Portugal and Switzerland
    Jun 25 2018/ 0 Comment
    25 June 2018 ASX Announcement Penthrox approved in Portugal and Switzerland. Medical Developments International Limited
  • MVP signs exclusive Distribution Deal for Iran
    May 29 2018/ 0 Comment
    29 May 2018 ASX Announcement MVP signs exclusive Distribution Deal for Iran. Penthrox approved in Romania, Bulgaria, Slo
  • Trading Update
    May 14 2018/ 0 Comment
    14 May 2018 ASX Announcement Trading Update Medical Developments International Limited (ASX: MVP) CEO, Mr. John Sharman,
  • Penthrox approved in Finland
    Apr 27 2018/ 0 Comment
    24 April 2018 ASX Announcement Penthrox approved in Finland Medical Developments International Limited (ASX: MVP) is del
  • Penthrox is approved in Canada
    Apr 10 2018/ 0 Comment
    10 April 2018 ASX Announcement Penthrox is approved in Canada Medical Developments International Limited (ASX:MVP), anno
  • Penthrox approved in Germany
    Apr 4 2018/ 0 Comment
    5 April 2018 ASX Announcement Penthrox approved in Germany Medical Developments International Limited (ASX: MVP) is deli
  • Penthrox approved in Sweden, Norway, Poland and Croatia
    Mar 26 2018/ 0 Comment
    27 March 2018 ASX Announcement Penthrox approved in Sweden, Norway, Poland and Croatia Medical Developments Internationa
  • CEO Roadshow Presentation
    Feb 25 2018/ 0 Comment
    26 February 2018 ASX Announcement Please refer to the attached link for the latest version of the CEO Roadshow Presentat
  • Stage II success for new manufacturing technology – Lidocaine
    Feb 20 2018/ 0 Comment
    20 February 2018 ASX ANNOUNCEMENT ?Stage II success for new manufacturing technology: Lidocaine Medical Developments Int
  • First Penthrox order received for Austria
    Feb 18 2018/ 0 Comment
    19 February 2018 ASX Announcement Penthrox : First order received for Austria Medical Developments International Limited
  • Penthrox approved in Estonia
    Feb 18 2018/ 0 Comment
    19 February 2018 ASX Announcement Penthrox approved in Estonia Medical Developments International Limited (ASX: MVP) is
  • MVP – Half Year Report and Accounts
    Feb 15 2018/ 0 Comment
    16 February 2018 HALF-YEAR REPORT Pursuant to listing rule 4.2A, please find following Medical Developments Internationa
  • MVP signs major deal with Walgreens in the USA
    Feb 12 2018/ 0 Comment
    12 February 2018 ASX ANNOUNCEMENT MVP signs major deal with Walgreens in the USA Medical Developments International Limi
  • Penthrox approved in Austria
    Jan 29 2018/ 0 Comment
    29 January 2018 ASX Announcement Penthrox approved in Austria Medical Developments International Limited (ASX: MVP) is d
  • Penthrox approved in Iceland
    Jan 22 2018/ 0 Comment
    22 January 2018 ASX Announcement Penthrox approved in Iceland Medical Developments International Limited (ASX: MVP) is d
  • ASX Announcement: Penthrox approved in another 22 European countries
    Dec 11 2017/ 0 Comment
    12 December 2017 ASX Announcement Penthrox approved in another 22 European countries Medical Developments International
  • AGM – Chairman’s and CEO’s Address to Shareholders
    Oct 27 2017/ 0 Comment
    27 October 2017 ASX ANNOUNCEMENT Chairman?s and CEO?s Address to Shareholders MVP today held its? 2017 AGM. Please refer
  • Penthrox approved in Mexico
    Oct 18 2017/ 0 Comment
    18 October 2017 ASX ANNOUNCEMENT Penthrox approved in Mexico Medical Developments International Limited (ASX: MVP) is de
  • Penthrox is recommended for use in all UK ambulances
    Sep 26 2017/ 0 Comment
    26 September 2017 ASX ANNOUNCEMENT Penthrox is recommended for use in all UK ambulances Medical Developments Internation
  • CEO Roadshow Presentation
    Aug 18 2017/ 0 Comment
    18 August 2017 ASX announcement Please find attached a link to the latest CEO Roadshow Presentation Road Show Presentati
  • MVP FY17 Preliminary Final Report & Full Year Accounts
    Aug 18 2017/ 0 Comment
    18?August 2017 ASX ANNOUNCEMENT Medical Developments International Limited (ASX: MVP) is delighted to announce the relea
  • MVP signs Respiratory Device supply deal with Sam’s Club
    Aug 2 2017/ 0 Comment
    2 August 2017 ASX ANNOUNCEMENT MVP signs Respiratory Device supply deal with Sam?s Club Medical Developments Internation
  • Penthrox Regulatory Dossier accepted for review in Canada
    Jun 15 2017/ 0 Comment
    15 June 2017 ASX ANNOUNCEMENT Penthrox Regulatory Dossier accepted for review in Canada Medical Developments Internation
  • Presentation at Jefferies 2017 Global Healthcare Conference – June 9, New York
    Jun 8 2017/ 0 Comment
    8 June 2017 ASX ANNOUNCEMENT Presentation at Jefferies 2017 Global Healthcare Conference – June 9, New York Medical Deve
  • Presentation at Jefferies 2017 Global Healthcare Conference – June 9, New York
    Jun 8 2017/ 0 Comment
    8 June 2017 ASX ANNOUNCEMENT Presentation at Jefferies 2017 Global Healthcare Conference – June 9, New York Medica
  • MVP signs significant Manufacturing Development Project with CSIRO
    Jun 4 2017/ 0 Comment
    5 June 2017 ASX ANNOUNCEMENT MVP signs significant Manufacturing Development Project with CSIRO. Medical Developments In
  • Penthrox replaces Nitrous Oxide in New Zealand Ambulance
    Jun 2 2017/ 0 Comment
    2 June 2017 ASX ANNOUNCEMENT Penthrox replaces Nitrous Oxide in New Zealand Ambulance Medical Developments International
  • MVP Respiratory Devices now available in Costco and circa 10,000 USA pharmacies
    Apr 27 2017/ 0 Comment
    27 April 2017 ASX ANNOUNCEMENT MVP Respiratory Devices now available in Costco and circa 10,000 USA pharmacies Medical D
  • Penthrox licensing deal for Russia
    Apr 12 2017/ 0 Comment
    12 April 2017 ASX ANNOUNCEMENT Penthrox licensing deal for Russia Medical Developments International Limited (ASX: MVP)
  • MVP’s Respiratory Devices in all Kmart pharmacies in the USA
    Apr 10 2017/ 0 Comment
    10 April 2017 ASX ANNOUNCEMENT MVP’s Respiratory Devices in all Kmart pharmacies in the USA. Medical Developments Intern
  • MVP’s Respiratory Devices in all Kmart pharmacies in the USA
    Apr 10 2017/ 0 Comment
    10 April 2017 ASX ANNOUNCEMENT MVP’s Respiratory Devices in all Kmart pharmacies in the USA. Medical Developments
  • MVP’s Respiratory Devices in all Walmart stores in the USA
    Apr 10 2017/ 0 Comment
    10 April 2017 ASX ANNOUNCEMENT MVP’s Respiratory Devices in all Walmart stores in the USA. Medical Developments Internat
  • MVP?s Respiratory Devices in all Walmart stores in the USA
    Apr 10 2017/ 0 Comment
    10 April 2017 ASX ANNOUNCEMENT MVP?s Respiratory Devices in all Walmart stores in the USA. Medical Developments Internat
  • Penthrox: Second Order for UK and Ireland
    Mar 2 2017/ 0 Comment
    2 March 2017 ASX ANNOUNCEMENT Penthrox: Second order for UK and Ireland Medical Developments International Limited (ASX:
  • FY17 HY Results
    Feb 20 2017/ 0 Comment
    20th February 2017 HALF-YEAR REPORT Pursuant to listing rule 4.2A, please find following Medical Developments Internatio
  • Penthrox Launched in France and Belgium and first sales
    Feb 7 2017/ 0 Comment
    8 February 2017 ASX ANNOUNCEMENT Penthrox launched in France and Belgium and first sales. Medical Developments Internati
  • Penthrox – European Update
    Feb 7 2017/ 0 Comment
    7 February 2017 ASX ANNOUNCEMENT Penthrox: European update Medical Developments International Limited (ASX: MVP) provide
  • MVP CEO Claims Award
    Dec 22 2016/ 0 Comment
    23 December 2016 PRESS RELEASE MVP CEO wins Biotech Daily 2016 CEO of the Year??????????????????????????????????????????
  • Penthrox approved for sale in Taiwan
    Dec 7 2016/ 0 Comment
    8 December 2016 ASX ANNOUNCEMENT Penthrox approved for sale in Taiwan Medical Developments International Limited (ASX: M
  • Penthrox submitted for Regulatory Approval in 22 European Countries
    Nov 29 2016/ 0 Comment
    29 November 2016 ASX ANNOUNCEMENT PENTHROX SUBMITTED FOR REGULATORY APPROVAL IN 22 EUROPEAN COUNTRIES Medical Developmen
  • POST TRUMP: Business as usual – MVP signs a Respiratory deal and receives first order
    Nov 13 2016/ 0 Comment
    14 November 2016 POST TRUMP: Business as usual – MVP signs a Respiratory deal and receives first order Medical Dev
  • MVP signs major deal with CSIRO
    Oct 28 2016/ 0 Comment
    28 October 2016 MVP signs major deal with CSIRO on exclusive rights for some key drugs Medical Developments Internationa
  • MVP FY16 Annual Report and AGM Notice of Meeting
    Sep 23 2016/ 0 Comment
    Please refer to the following link for a copy of the?MVP FY16 Annual Report Also attached is a link to the MVP AGM NOM
  • MVP Signs Exclusive Licensing and Distribution Agreement with Purdue Pharma Canada for Penthrox in Canada
    Sep 12 2016/ 0 Comment
    12 September 2016 MVP Signs Exclusive Licensing and Distribution Agreement with Purdue Pharma Canada for Penthrox? in Ca
  • Penthrox receives regulatory approval in the UAE
    Sep 9 2016/ 0 Comment
    9 September 2016 ASX ANNOUNCEMENT Penthrox receives regulatory approval in the UAE Medical Developments International Li
  • ASX Announcement – Licensing deal for Korea
    Sep 5 2016/ 0 Comment
    6 September 2016 ASX ANNOUNCEMENT Licensing deal for Korea Medical Developments International Limited (?MDI?) (ASX: MVP)
  • FY16 Full Year Results
    Aug 17 2016/ 0 Comment
    18 August 2016 ASX ANNOUNCEMENT FY16 Full Year Results For details relating to the full ASX Release, please click on the
  • European Penthrox Update
    Aug 11 2016/ 0 Comment
    12 August 2016 ASX ANNOUNCEMENT European Penthrox? Update. Medical Developments International Limited (ASX: MVP) advises
  • USA Penthrox Update & USA Respiratory Update
    Aug 9 2016/ 0 Comment
    9 August 2016 ASX ANNOUNCEMENTS – USA Penthrox Update & USA Respiratory Update USA : Penthrox update Medical D
  • USA Penthrox Update & USA Respiratory Update
    Aug 9 2016/ 0 Comment
    9 August 2016 ASX ANNOUNCEMENTS – USA Penthrox Update & USA Respiratory Update USA : Penthrox update Medical D
  • Vive La France: Regulatory Approval Received
    Jun 20 2016/ 0 Comment
    21 June 2016 ASX ANNOUNCEMENT Vive La France: Regulatory Approval Received Medical Developments International Limited (A
  • Licensing deal for Canada
    Jun 14 2016/ 0 Comment
    14 June 2016   ASX ANNOUNCEMENT ? Licensing deal for Canada Medical Developments International Limited (ASX: MVP) i
  • MVP signs Respiratory deals in the United States and Portugal
    May 25 2016/ 0 Comment
    25 May 2016 ASX ANNOUNCEMENT MVP signs Respiratory deals in the United States and Portugal Medical Developments Internat
  • Bell Potter and Patersons Initiate Coverage on MVP
    Apr 6 2016/ 0 Comment
    Bell Potter and Patersons has recently initiated coverage on Medical Developments International (ASX:MVP). ?For a copy o
  • Half Year Report 2015-16
    Feb 18 2016/ 0 Comment
    18 February 2016 HALF YEAR REPORT 2015-2016 For a copy of the Half Year Report 2015-16, please click on the following li
  • MVP Completes Acquisition of Breath-A-Tech
    Feb 5 2016/ 0 Comment
    5 February 2016 ASX ANNOUNCEMENT MVP Completes Acquisition of Breath-A-Tech Medical Developments International Limited (
  • ASX:MVP Shareholder News – January 2016
    Feb 1 2016/ 0 Comment
    To read?our first edition of ASX:MVP Shareholder News, click on the link:?Shareholder News January 2016?
  • Penthrox Launch in the UK and Pricing Approval for Ireland
    Jan 27 2016/ 0 Comment
    27 January 2016 ASX ANNOUNCEMENT Penthrox Launch in the UK and Pricing Approval for Ireland Medical Developments Interna
  • FDA Approves New Range of Respiratory Devices
    Jan 27 2016/ 0 Comment
    27 January 2016 ASX ANNOUNCEMENT FDA Approves New Range of Respiratory Devices Medical Developments International Limite
  • MVP acquires Avita Medical’s Australian Respiratory Business
    Dec 23 2015/ 0 Comment
    24 December 2015 ASX ANNOUNCEMENT MVP acquires Avita Medical’s Australian Respiratory Business Medical Developments Inte
  • MVP acquires Avita Medical?s Australian Respiratory Business
    Dec 23 2015/ 0 Comment
    24 December 2015 ASX ANNOUNCEMENT MVP acquires Avita Medical?s Australian Respiratory Business Medical Developments Inte
  • ASX Announcement: Green Whistle receives regulatory and marketing approval in the United Kingdom
    Oct 28 2015/ 0 Comment
    28 October 2015 ASX ANNOUNCEMENT Green Whistle receives regulatory and marketing approval in the United Kingdom Medical
  • Green Whistle receives regulatory approval in Singapore
    Sep 23 2015/ 0 Comment
    23 September 2015 ASX ANNOUNCEMENT ?Green Whistle receives regulatory approval in Singapore Medical Developments Interna
  • MVP completes European Distribution deal with Mundipharma
    Sep 14 2015/ 0 Comment
    14 September 2015 ASX ANNOUNCEMENT Mundipharma and Medical Developments International announce a new alliance for the co
  • FY15 Chairman/CEO Report and Annual Accounts
    Aug 21 2015/ 0 Comment
    21 August 2015 ASX ANNOUNCEMENT Preliminary Final Report and Full Year Accounts Medical Developments International Limit
  • Major licensing deal for Europe
    Jun 28 2015/ 0 Comment
      29 June 2015 ASX ANNOUNCEMENT Major licensing deal for Europe Medical Developments International Limited (ASX: MV
  • More Penthrox Licensing Agreements Expected
    May 12 2015/ 0 Comment
    12 May 2015 ASX ANNOUNCEMENT More Penthrox Licensing Agreements Expected To facilitate distributing Penthrox internation
  • Near term planning for the globalisation of Penthrox
    May 8 2015/ 0 Comment
    8 May 2015 ASX ANNOUNCEMENT Near term planning for the globalisation of Penthrox The approval of Penthrox for use in the
  • Penthrox Regulatory Approval in UK and Europe
    May 6 2015/ 0 Comment
    6 May 2015 ASX Announcement Penthrox successfully completes its Decentralised Regulatory Approval Procedure in Europe Me
  • Trading Update – 1 May 2015
    May 1 2015/ 0 Comment
    Trading Update – 1 May 2015
  • FY15 Half Year Results
    Feb 20 2015/ 0 Comment
    MDI FY15 HY Report (Final)
  • ASX Announcement – Green Whistle: Positive “Regulatory Approval” feedback from European Regulatory Authorities
    Jan 19 2015/ 0 Comment
    Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received positive feedback fro
  • ASX Announcement – Green Whistle: Positive ?Regulatory Approval? feedback from European Regulatory Authorities
    Jan 19 2015/ 0 Comment
    Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received positive feedback fro
  • ASX Announcement – Major European deal for Penthrox
    Sep 26 2014/ Comments Off on ASX Announcement – Major European deal for Penthrox
    Medical Developments International (MVP) is delighted to announce it has entered into an exclusive Distribution, License
  • ASX Announcement – Supply Agreement for Respiratory Products in the UK
    Sep 5 2014/ 0 Comment
    Medical Developments International (MVP) is delighted to advise it has entered into an exclusive agreement with PSUK to
  • ASX Announcement ? Supply Agreement for Respiratory Products in the UK
    Sep 5 2014/ 0 Comment
    Medical Developments International (MVP) is delighted to advise it has entered into an exclusive agreement with PSUK to
  • Trial conducted to evaluate newer methods of pain relief for limb injuries
    Jul 9 2014/ Comments Off on Trial conducted to evaluate newer methods of pain relief for limb injuries
    SINGAPORE: A year-long trial is being conducted on two medications to ensure patients get a faster and more effective de
  • ASX Announcement – Green Whistle receives regulatory approval in South Africa
    Jul 4 2014/ Comments Off on ASX Announcement – Green Whistle receives regulatory approval in South Africa
    Medical Developments International Limited (ASX:MVP) has received approval from the Medicines Control Council (MCC) in S
  • ASX Announcement: Overseas Registration and Partnership Update
    May 29 2014/ Comments Off on ASX Announcement: Overseas Registration and Partnership Update
    Update on European Marketing Application In November 2013, Medical Developments International (MVP) submitted its regula
  • ASX Announcement – Successful Clinical Study Results
    Sep 11 2013/ Comments Off on ASX Announcement – Successful Clinical Study Results
    ?THOROUGH QT/QTc? PENTHROX? CLINICAL TRIAL SUCCESSFULLY MEETS ALL PRIMARY AND SECONDARY OBJECTIVES Medical Developments
  • CSIRO Successful completion of first milestone
    Jun 10 2013/ Comments Off on CSIRO Successful completion of first milestone
    In August 2012 MVP announced it had entered into a research and development program with the CSIRO designed to introduce
  • Chairman’s and CEO’s Report
    Feb 25 2013/ Comments Off on Chairman’s and CEO’s Report
    Download CEO’s & Chairman’s Report as PDF RECORD PROFIT STRONG GROWTH AND 3 CENTS FULLY FRANKED INTERIM
  • ASX Announcement
    Jan 21 2013/ Comments Off on ASX Announcement
    20 January 2013 ASX ANOUNCEMENT RESULTS OF PIVOTAL PHASE III CLINICAL TRIAL Methoxyflurane inhalation demonstrated to be
  • ASX Announcement
    Jan 2 2013/ Comments Off on ASX Announcement
    27 December 2012 ASX ANNOUNCEMENT Significant Developments and Opportunities in Asthma Devices Consistent with MVP?s str
  • ASX Announcement
    Oct 30 2012/ Comments Off on ASX Announcement
    2012 Annual General Meeting Address to Shareholders by Chairman and CEO 24 October, 2012 ADDRESS BY CHAIRMAN ? MR. DAVID
  • CHAIRMAN’S AND CEO’S REPORT
    Aug 23 2012/ Comments Off on CHAIRMAN’S AND CEO’S REPORT
    CONTINUING GROWTH AND RECORD PROFIT Medical Developments International Limited. (“MDI”) (ASX:MVP) delivered a Record Net
  • CHAIRMAN?S AND CEO?S REPORT
    Aug 23 2012/ Comments Off on CHAIRMAN?S AND CEO?S REPORT
    CONTINUING GROWTH AND RECORD PROFIT Medical Developments International Limited. (?MDI?) (ASX:MVP) delivered a Record Net
  • LAST PATIENT ENROLLED: EUROPEAN PHASE III PIVOTAL TRIAL COMPLETED
    Aug 6 2012/ Comments Off on LAST PATIENT ENROLLED: EUROPEAN PHASE III PIVOTAL TRIAL COMPLETED
    Medical Developments International Limited (ASX: MVP) is delighted to confirm the 300th and final patient has been enrol
  • FURTHER EARNINGS GUIDANCE
    Jun 27 2012/ Comments Off on FURTHER EARNINGS GUIDANCE
    The Board of Directors of Medical Developments International Ltd. (ASX:MVP) announced a profit guidance upgrade on 22 Ju
  • MEDICAL DEVELOPMENTS EXPANDS INTO EUROPE
    May 11 2012/ Comments Off on MEDICAL DEVELOPMENTS EXPANDS INTO EUROPE
    Medical Developments is pleased to announce it has established a UK subsidiary company and appointed a European Business
  • May 7 2012/ Comments Off on
    Further Earnings Guidance The Board of Directors of Medical Developments International Ltd. (ASX:MVP) advise the market
  • DRP Results
    Apr 13 2012/ Comments Off on DRP Results
    Medical Developments is delighted to confirm the following results from its Interim Dividend declared on 23 February, 20
  • Investors/Media
  • Financial Reports
  • Board of Directors/Management
  • Media Centre
  • Corporate Governance
  • Diversity Policy
  • Share Trading Policy
  • Interviews/Analyst Reports

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • MVP Completes $25m Placement

    14 December 2020 ASX ANNO...

  • EU Transition and Trading Update

    3 December 2020 ASX ANNOU...

  • MVP Board Re-organisation

    3 December 2020 ASX ANNOU...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me


Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.